Bank of America
LKFT

Bank of America’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bank of America’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$622K Sell
20,725
-10,244
-33% -$339K ﹤0.01% 4781
2025
Q4 		$1.01M Buy
30,969
+20
+0.1% +$646 ﹤0.01% 4518
2025
Q3 		$1.07M Buy
30,949
+643
+2% +$20.6K ﹤0.01% 5284
2025
Q2 		$848K Sell
30,306
-29,300
-49% -$785K ﹤0.01% 5400
2025
Q1 		$1.5M Buy
59,606
+37,152
+165% +$939K ﹤0.01% 4929
2024
Q4 		$617K Buy
22,454
+3,684
+20% +$103K ﹤0.01% 5386
2024
Q3 		$540K Sell
18,770
-16,493
-47% -$449K ﹤0.01% 5436
2024
Q2 		$874K Buy
35,263
+28,769
+443% +$816K ﹤0.01% 4982
2024
Q1 		$209K Sell
6,494
-14,318
-69% -$532K ﹤0.01% 5866
2023
Q4 		$846K Buy
20,812
+1,365
+7% +$50.2K ﹤0.01% 5109
2023
Q3 		$672K Sell
19,447
-837
-4% -$32.6K ﹤0.01% 5101
2023
Q2 		$825K Buy
20,284
+4,181
+26% +$171K ﹤0.01% 4921
2023
Q1 		$622K Buy
16,103
+13,270
+468% +$545K ﹤0.01% 5224
2022
Q4 		$126K Sell
2,833
-1,946
-41% -$81.9K ﹤0.01% 6141
2022
Q3 		$204K Buy
4,779
+714
+18% +$36.6K ﹤0.01% 5964
2022
Q2 		$226K Sell
4,065
-1,203
-23% -$71.3K ﹤0.01% 6001
2022
Q1 		$326K Sell
5,268
-33,744
-86% -$2.07M ﹤0.01% 6126
2021
Q4 		$2.15M Buy
39,012
+30,269
+346% +$1.58M ﹤0.01% 4478
2021
Q3 		$460K Buy
8,743
+4,154
+91% +$247K ﹤0.01% 5718
2021
Q2 		$316K Sell
4,589
-13,462
-75% -$1.03M ﹤0.01% 5766
2021
Q1 		$1.39M Buy
18,051
+5,551
+44% +$511K ﹤0.01% 4546
2020
Q4 		$1.24M Sell
12,500
-2,863
-19% -$350K ﹤0.01% 4319
2020
Q3 		$2.18M Buy
15,363
+2,910
+23% +$485K ﹤0.01% 3613
2020
Q2 		$2.46M Sell
12,453
-24,332
-66% -$5.04M ﹤0.01% 3452
2020
Q1 		$7.21M Sell
36,785
-31,022
-46% -$6.67M ﹤0.01% 2341
2019
Q4 		$14M Sell
67,807
-73,654
-52% -$13.6M ﹤0.01% 2219
2019
Q3 		$21.6M Buy
141,461
+115,950
+455% +$19M ﹤0.01% 1769
2019
Q2 		$3.29M Buy
25,511
+17,554
+221% +$2.08M ﹤0.01% 3614
2019
Q1 		$937K Sell
7,957
-372
-4% -$37.5K ﹤0.01% 4564
2018
Q4 		$765K Sell
8,329
-61
-0.7% -$6.18K ﹤0.01% 4614
2018
Q3 		$944K Sell
8,390
-1,368
-14% -$145K ﹤0.01% 4523
2018
Q2 		$899K Buy
9,758
+1,025
+12% +$99.4K ﹤0.01% 4535
2018
Q1 		$871K Sell
8,733
-1,569
-15% -$169K ﹤0.01% 4477
2017
Q4 		$967K Buy
10,302
+2,831
+38% +$268K ﹤0.01% 4509
2017
Q3 		$761K Buy
7,471
+2,180
+41% +$191K ﹤0.01% 4681
2017
Q2 		$405K Buy
5,291
+912
+21% +$76.7K ﹤0.01% 5003
2017
Q1 		$377K Buy
4,379
+694
+19% +$50K ﹤0.01% 5036
2016
Q4 		$237K Buy
3,685
+2,683
+268% +$165K ﹤0.01% 5246
2016
Q3 		$64K Buy
1,002
+375
+60% +$21.1K ﹤0.01% 5634
2016
Q2 		$35K Buy
627
+46
+8% +$2.31K ﹤0.01% 5991
2016
Q1 		$24K Buy
581
+331
+132% +$15.4K ﹤0.01% 6063
2015
Q4 		$16K Sell
250
-37,989
-99% -$1.94M ﹤0.01% 6506
2015
Q3 		$1.56M Buy
+38,239
New +$2.2M ﹤0.01% 3979

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America's LKFT Position: Q1 2026 in Review

Bank of America reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 33% in Q1 2026, selling an estimated $339K and leaving 20,725 shares worth $622K. The position accounts for ﹤0.01% of the portfolio, ranked #4781.

Bank of America first reported a position in LKFT in Q3 2015 and has held it in 43 quarters since. The position peaked at $21.6M in Q3 2019. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Bank of America held 20,725 shares of Lakefront Biotherapeutics American Depositary Shares worth $622K as of Q1 2026.
  • Bank of America sold 10,244 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $339K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4781 holding.
  • Bank of America first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and has held it in 43 quarters since.
  • Bank of America's Lakefront Biotherapeutics American Depositary Shares position peaked at $21.6M in Q3 2019.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.